Skip to main content

Neafsey Lab

The Neafsey Lab uses genomic, transcriptomic, and serologic data to make significant scientific discoveries in malaria and other vector-borne diseases. By studying the genetics of microbes, their carriers (like mosquitoes), and their human hosts, the lab develops new molecular and bioinformatic tools that support public health efforts. Their research helps improve treatments and deepens our understanding of how these diseases spread and evolve.

Phone 617-432-5404
Location

665 Huntington Avenue 
Building 1, Room 103 
Boston, MA, 02115

Photo of mosquitos overlapping with genomic data.

Genomic Epidemiology of Malaria

About the Neafsey Lab

The Neafsey Lab uses cutting-edge genomic, transcriptomic sequencing, and serologic data to explore vector-borne infectious diseases, with a primary focus on malaria. Our research integrates insights from population genetics and molecular evolution to investigate complex interactions between pathogens, their vectors, and hosts. Through innovative approaches, we aim to uncover new biological insights, enhance therapeutic effectiveness, and develop advanced tools in molecular biology and bioinformatics that support global public health.

Support Harvard Chan School

Every gift contributes to our mission of building a world where everyone can thrive. To learn more about how you can support The Neafsey Lab, please contact Carter Brown.

What We Do

Malaria represents a co-evolutionary triangle between parasites, vectors, and human hosts. The evolutionary adaptations that impact disease epidemiology leave a signature in the genomes of each member of these triangles. By applying population genomic methods, and generating other data such as transcriptomic and serologic profiles, we can better understand the basic biology and epidemiology of vector-borne diseases, and apply that knowledge to their control.


The Studio: Combatting the global threat of dengue fever

Featuring speaker Daniel Neafsey